Wertpapierdatensatz · archiviertes Quartal
CTMX
CytomX Therapeutics, Inc. · Healthcare · Biotechnology
49Erfasste Halter
-1Δ Inhaber
71.30MGehaltene Aktien
$303.77MGemeldeter Wert
+0Neue Positionen
−1Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -2.0% ·
Aktienfluss +23.5% ·
neue Nettopositionen -2.0%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | +11 | 136.41M | $511.64M | +18 | −7 |
| Q1 2026 | 64 | +15 | 111.19M | $522.57M | +20 | −5 |
| Q4 2025 | 49 | -1 | 71.30M | $303.77M | — | −1 |
| Q3 2025 | 14 | 0 | 41.38M | $131.99M | — | — |
| Q2 2025 | 11 | 0 | 36.17M | $82.10M | — | — |
| Q1 2025 | 8 | +1 | 8.01M | $5.09M | +1 | — |
| Q4 2024 | 7 | 0 | 9.00M | $9.27M | +1 | −1 |
| Q3 2024 | 6 | 0 | 8.17M | $9.64M | — | — |
| Q2 2024 | 6 | — | 7.95M | $9.70M | — | — |
Wer es hält · Q4 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 24.69M | +60.4% | $105.17M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 2 | The Vanguard Group ✦ (passiv) | 8.48M | -5.3% | $36.11M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 3 | Point72 Asset Management ✦ | 5.19M | +27.6% | $22.11M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passiv) | 5.14M | +697.1% | $21.90M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | Balyasny Asset Management L.P. | 3.87M | — | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Financial Engines Advisors L.L.C. | 3.83M | — | $16.31M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 3.67M | +54.0% | $15.63M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 8 | Goldman Sachs Group ✦ | 2.46M | +449.6% | $10.48M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 1.56M | +113.9% | $6.65M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 1.53M | -2.8% | $6.50M | 0.0% | ▼ Trim | 7 | SEC ↗ ×2 |
| 11 | Dimensional Fund Advisors Lp | 1.29M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | Marshall Wace ✦ | 1.16M | +4.7% | $4.93M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 13 | Qube Research & Technologies Ltd | 1.06M | — | $4.52M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Susquehanna International Group, Llp | 981.60K | — | $4.18M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Bank Of America Corp /De/ | 876.30K | — | $3.73M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 16 | Jane Street Group, Llc | 607.22K | — | $2.59M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Assenagon Asset Management S.A. | 592.70K | — | $2.52M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | First Trust Advisors Lp | 423.17K | — | $1.80M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Northern Trust Corp | 415.18K | — | $1.77M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 401.19K | +25.6% | $1.71M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 21 | UBS Group AG | 370.74K | — | $1.58M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 22 | Citadel Advisors ✦ | 342.30K | -81.0% | $1.46M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 23 | Barclays Plc | 336.52K | — | $1.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 24 | Bank of New York Mellon Corp | 328.25K | — | $1.40M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 25 | Raymond James Financial Inc | 316.97K | — | $1.35M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 26 | Millennium Management ✦ | 289.65K | -79.1% | $1.23M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 27 | Ameriprise Financial Inc | 229.60K | — | $988,976 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Sei Investments Co | 124.12K | — | $528,768 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | LPL Financial LLC | 113.44K | — | $483,254 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Canada Pension Plan Investment Board | 104.20K | — | $443,892 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citigroup Inc | 96.33K | — | $410,349 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Hrt Financial Lp | 71.87K | — | $306,000 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Charles Schwab Investment… | 68.69K | — | $292,607 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Squarepoint Ops LLC | 49.90K | — | $212,561 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Tidal Investments LLC | 45.76K | — | $194,950 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Hsbc Holdings Plc | 24.46K | — | $104,200 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 37 | JPMorgan Chase ✦ | 24.36K | -24.6% | $103,786 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 38 | Simplex Trading, Llc | 24.05K | — | $102,457 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Mariner, LLC | 22.18K | — | $94,487 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Invesco Ltd. | 21.98K | — | $93,618 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Osaic Holdings, Inc. | 19.41K | — | $82,686 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 42 | MIRAE ASSET GLOBAL ETFS HOLDINGS… | 15.96K | — | $66,389 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Victory Capital Management Inc | 14.72K | — | $62,716 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Bank Of Nova Scotia | 13.66K | — | $58,196 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Mirae Asset Global Investments Co.… | 8.23K | — | $35,073 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Wells Fargo & Company/Mn | 6.61K | — | $28,137 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 47 | Bnp Paribas Financial Markets | 2.83K | — | $12,034 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Daiwa Securities Group Inc. | 564 | — | $2,000 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Royal Bank Of Canada | 214 | — | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Renaissance Technologies | $8.12M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 178 Inhaber, 193.14M Anteile, $906.86M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q4 2025 ·
Methodik ·
Über die API abrufen